3.30.16 | Research and Clinical Trials
Outcomes from SWHR’s Multi-stakeholder Workshop on Achieving Meaningful Subgroup Data in Clinical Trials Released
SWHR released the outputs of its two-day workshop “Achieving Meaningful Subgroup Data in Clinical Trial Design and Development: Scientific Approaches and Considerations.”
12.15.15 | Research and Clinical Trials
Second Annual CURE-UAB Meeting Emphasizes Need For Public Awareness, Research Funding
Dr. Liliana Losada, associate director of scientific programs at SWHR recently attended the Second International Congress on Underactive Bladder(CURE-UAB) in Denver, Colorado.
7.8.15 | Research and Clinical Trials
Congressional Briefing to Explore Biological Sex Differences’ Impact on Medical Research
Women’s health leaders press for female subjects to be included in basic research studies
6.12.15 | Research and Clinical Trials
SWHR Applauds NIH’s New Inclusion Of Sex As A Biological Variable
SWHR supports the National Institute of Health’s (NIH) move to include sex as a biological variable in future research.
5.5.15 | Research and Clinical Trials
SWHR Supports Reintroduction of the Research For All Act
United States Representatives Jim Cooper (D-TN) and Cynthia Lummis (R-WY) introduced the “Research for All Act of 2015” in Congress.
2.14.15 | Policy
Congressional Briefing Explores Biological Sex Differences in Medical Research
Women’s health leaders press for female subjects to be included in basic research
10.17.14 | Research and Clinical Trials
OSSD Offers Recommendations to Basic Scientists on New NIH Research Policies
SWHR would like to congratulate several leading members of the Organization for the Study of Sex Differences (OSSD) on the publication of their recent article "NIH initiative to balance sex of animals in preclinical studies: Generative questions to guide policy, implementation, and metrics."
10.17.14 | Policy
SWHR Applauds NIH-funded Research on Gender Bias in Pre-clinical and Clinical Studies
The National Institutes of Health (NIH) announced that it will invest $10.1 million in supplemental funding to support the research of more than 80 grantees to investigate the effects of sex in pre-clinical and clinical studies.
